Triethylene Glycol

Triethylene Glycol

SCHEMBL4014249

C=C(C)C(=O)O.COC.OCCOCCOCCO

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
TSHR P16473 8/20 0.43
MAPK1 P28482 1/20 0.43
THRB P10828 2/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 6/20 0.37
TP53 P04637 2/20 0.31
HIF1A Q16665 2/20 0.31
HSD17B10 Q99714 2/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TGFBR1 P36897 1/20 0.31
BLM P54132 1/20 0.30
PMP22 Q01453 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL2905298 1.00 MEN1 (0.48) MEN1KMT2ATSHRMAPK1THRB
Tetraethylene Glycol SCHEMBL9297935 1.00 MEN1 (0.48) MEN1KMT2ATSHRMAPK1THRB
Di(Hydroxyethyl)Ether SCHEMBL5136310 0.98 TSHR (0.46) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL10529387 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Hexaethylene Glycol SCHEMBL2347830 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL478108 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Tetraethylene Glycol SCHEMBL9314003 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL9485971 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL8604056 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Triethylene Glycol SCHEMBL8661497 0.96 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479101-B1 PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUE COHESIVES (FR) 2026-03-04 EP claimed
US-20250381318-A1 INTRAOCULAR LENS COMPOSITIONS Teleon Holding B.V. (NL) 2025-12-18 US claimed
EP-3934705-B1 INTRAOCULAR LENS COMPOSITIONS TELEON HOLDING B V (NL) 2025-11-19 EP claimed
US-12427226-B2 Intraocular lens compositions Teleon Holding B.V. (NL) 2025-09-30 US claimed
US-20250205360-A1 FUNCTIONALIZED CORE-SHELL NANOGEL SCAVENGER FOR IMMUNE MODULATION THERAPY UNIV NEW YORK STATE RES FOUND (US) 2025-06-26 US claimed
US-20250152772-A1 PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUES COHESIVES (FR) 2025-05-15 US claimed
WO-2025072355-A1 METHODS FOR AND COMPOSITIONS OF NON-PEG BIOCONJUGATES WITH ULTRA-HIGH DRUG-TO-AGENT RATIO BIOHYBRID SOLUTIONS HOLDINGS, INC. (US) 2025-04-03 WO claimed
EP-4479101-A1 PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUE Cohesives (FR) 2024-12-25 EP claimed
CN-118136967-B Lithium metal battery and preparation method and application thereof 蜂巢能源科技股份有限公司 2024-08-06 CN claimed
CN-118136967-A Lithium metal battery and preparation method and application thereof 蜂巢能源科技股份有限公司 2024-06-04 CN claimed
EP-2764065-B1 SACRIFICIAL ADHESIVE COATINGS ROCHAL IND LLC (US) 2017-03-22 EP claimed
US-20160206522-A1 MICROCAPSULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US claimed
CN-105431225-A Microcapsule TAKASAGO PERFUMERY CO LTD 2016-03-23 CN claimed
US-20150252144-A1 Biodegradable Cross-Linked Polymer, Vascular Stent and Manufacturing Methods Therefor FARWAVE APPLIED MATERIAL (SHANGHAI) CO., LTD (CN) 2015-09-10 US claimed
EP-2907834-A2 BIODEGRADABLE CROSS-LINKED POLYMER, VASCULAR STENT AND MANUFACTURING METHODS THEREFOR Shanghai MicroPort Medical (Group) Co., Ltd. (CN) 2015-08-19 EP claimed
WO-2015016369-A1 MICROCAPSULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-02-05 WO claimed
EP-2832441-A1 Microcapsules Takasago International Corporation (JP) 2015-02-04 EP claimed
EP-2764065-A1 SACRIFICIAL ADHESIVE COATINGS Rochal Industries, LLP (US) 2014-08-13 EP claimed
WO-2013052276-A1 SACRIFICIAL ADHESIVE COATINGS ROCHAL INDUSTRIES, LLP (US) 2013-04-11 WO claimed
US-8263720-B1 Sacrificial adhesive coatings ROCHAL INDUSTRIES, LLP (US) 2012-09-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250205360-A1 FUNCTIONALIZED CORE-SHELL NANOGEL SCAVENGER FOR IMMUNE MODULATION THERAPY TST, CD44, TSLP MEN1 4701/4885KMT2A 3741/4885TSHR 196/4885
US-20160206522-A1 MICROCAPSULES MITF, PLIN5, MLEC MEN1 805/4885KMT2A 4090/4885TSHR 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.